#biotech

📰News 📈 Stocks

EyePoint Pharmaceuticals Shares Slide Following Failed Phase 3 AMD Trial

October 20, 2026 (21 days ago)

EyePoint Pharmaceuticals shares are under pressure as investors weigh a failed Phase 3 trial and controversial data exclusions in the LUGANO study,…

EYPT

🌍 US Read More →

🏢Release 📈 Stocks

Ultima Genomics Doubles Sequencing Output to Enable $60 Whole Genome Costs

October 20, 2026 (21 days ago)

Ultima Genomics scales its UG200 platform with Solaris 2.0 Max, doubling sequencing throughput and aggressively targeting the $60 per genome price point…

Ultima Genomics

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

PDS Biotechnology Appoints 3 Pharma Veterans to Board to Bolster Pipeline

October 20, 2026 (21 days ago)

PDS Biotechnology adds three industry veterans to its board to accelerate the development of PDS0301 for metastatic colorectal cancer and drive potential…

PDSB

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Abiologics Appoints Chief AI Officer to Accelerate Synthetic Drug Discovery

October 20, 2026 (21 days ago)

Abiologics bolsters its R&D capabilities by hiring an AI protein design expert to advance its proprietary platform for creating synthetic D-protein therapeutics…

Abiologics

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Maxion Therapeutics Appoints Former Pfizer CSO to Board of Directors

October 20, 2026 (21 days ago)

Maxion Therapeutics adds former Pfizer executive to its board, aiming to leverage deep R&D expertise to advance its pipeline of life-changing medical…

Maxion Therapeutics

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Eloxx Pharmaceuticals Appoints Industry Veteran Germano to Board of Directors

October 19, 2026 (21 days ago)

Eloxx Pharmaceuticals adds 35-year industry veteran Mr. Germano to its board, leveraging his extensive experience from Pfizer and Entera Bio to guide…

ELOX

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Mineralys Therapeutics Adds Two Board Members Ahead of December PDUFA Date

October 19, 2026 (21 days ago)

Mineralys Therapeutics strengthens its board with two commercial experts as the company approaches a critical December 22 regulatory milestone for its drug…

MLYS

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Repairon Appoints Dr. Detlef Schumann as COO to Drive Clinical Growth

October 19, 2026 (22 days ago)

Repairon bolsters its executive leadership team with the appointment of Dr. Detlef Schumann as COO, tasking the biotech veteran with advancing clinical…

Repairon

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Colossal Biosciences Repatriates Rare Moa Egg to New Zealand Partners

October 19, 2026 (22 days ago)

Colossal Biosciences facilitates the return of a rare moa egg to New Zealand, strengthening collaborative efforts in regional de-extinction research programs.

Colossal Biosciences

🌍 OCEANIA Read More →

🏢Release 📈 Stocks

KRAS Inhibitor Market Expands as Roche, Lilly, and Merck Advance Pipelines

October 19, 2026 (22 days ago)

The KRAS inhibitor sector gains momentum as Roche, Eli Lilly, and Merck advance specialized oncology therapies, addressing a growing demand for targeted…

ROG LLY MRK

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

Riboscience to Present Phase 1b Data for ENPP1 Inhibitor RBS2418 at ESMO 2026

October 19, 2026 (22 days ago)

Riboscience prepares to showcase Phase 1b clinical data for its lead ENPP1 inhibitor, RBS2418, at the ESMO 2026 medical congress, marking a…

Riboscience

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

ACROBiosystems Hosts Innovation Day to Advance AI-Driven Drug Discovery

October 19, 2026 (22 days ago)

ACROBiosystems hosted its Innovation Day in California, gathering biotech experts to explore how experimental validation supports AI-driven drug discovery workflows.

688137.SS

🌍 AMERICAS Read More →